Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemia

BACKGROUND: While current chemotherapy has increased cure rates for children with acute lymphoblastic leukaemia (ALL), the largest number of relapsing patients are still stratified as medium risk (MR) at diagnosis (50–60%). This highlights an opportunity to develop improved relapse-prediction models...

Descripción completa

Detalles Bibliográficos
Autores principales: Alruwetei, Abdulmohsen M., Bendak, Katerina, Yadav, Babasaheb D., Carol, Hernan, Evans, Kathryn, Mayoh, Chelsea, Sutton, Rosemary, Marshall, Glenn M., Lock, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462974/
https://www.ncbi.nlm.nih.gov/pubmed/32536690
http://dx.doi.org/10.1038/s41416-020-0933-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462974/
https://www.ncbi.nlm.nih.gov/pubmed/32536690
http://dx.doi.org/10.1038/s41416-020-0933-4

Ejemplares similares